{
  "items": "19",
  "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish",
  "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.",
  "feed": [
    {
      "title": "With 51% Ownership in Strata Critical Medical, Inc. (NASDAQ:SRTA), Institutional Investors Have a Lot Riding on the Business",
      "url": "https://news.futunn.com/en/post/66144324/with-51-ownership-in-strata-critical-medical-inc-nasdaq-srta",
      "time_published": "20251213T140932",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Institutional investors own 51% of Strata Critical Medical, Inc. (NASDAQ:SRTA), indicating their significant influence and potential gains or losses from the company's performance. The company recently saw a 20% gain, pushing its one-year shareholder return to 26%. Insiders also hold a reasonable proportion of shares, signaling their continued confidence in the business.",
      "banner_image": "https://pubimg.futunn.com/2022050900000325796f6f7efc6.png?imageMogr2/thumbnail/76x76!/ignore-error/1/format/webp",
      "source": "\u5bcc\u9014\u725b\u725b",
      "category_within_source": "General",
      "source_domain": "\u5bcc\u9014\u725b\u725b",
      "topics": [
        {
          "topic": "financial_markets",
          "relevance_score": "0.922770"
        }
      ],
      "overall_sentiment_score": 0.184289,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.190646",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "When Will Strata Critical Medical, Inc. (NASDAQ:SRTA) Breakeven?",
      "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-srta/strata-critical-medical/news/when-will-strata-critical-medical-inc-nasdaqsrta-breakeven",
      "time_published": "20251212T160916",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Strata Critical Medical, Inc. (NASDAQ:SRTA) is predicted by analysts to breakeven and become profitable in 2026, after incurring a final loss in 2025. This projection relies on an optimistic annual growth rate of 171%. The company currently operates without debt, funding operations purely through shareholder equity, which reduces investment risk.",
      "banner_image": "https://images.simplywall.st/asset/chart/376809349-earnings-per-share-growth-1-dark-2/1765535717012",
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.933026"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.846716"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.703729"
        },
        {
          "topic": "finance",
          "relevance_score": "0.636968"
        }
      ],
      "overall_sentiment_score": 0.336795,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.324285",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "When Will Strata Critical Medical, Inc. (NASDAQ:SRTA) Breakeven?",
      "url": "https://www.sahmcapital.com/news/content/when-will-strata-critical-medical-inc-nasdaqsrta-breakeven-2025-12-12",
      "time_published": "20251212T151101",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Strata Critical Medical, Inc. (NASDAQ:SRTA), a logistic and medical service provider, is currently unprofitable but is expected to break even by 2026, according to analysts. The company is predicted to achieve profitability due to an aggressive 171% year-on-year growth rate and operates without debt, which reduces investment risk. Investors are keen to understand when the company will become profitable given its current loss-making status.",
      "banner_image": "https://images.simplywall.st/asset/chart/376809349-earnings-per-share-growth-1-dark-2/1765535717012",
      "source": "Sahm",
      "category_within_source": "General",
      "source_domain": "Sahm",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.915907"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.801472"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.749086"
        },
        {
          "topic": "finance",
          "relevance_score": "0.625364"
        }
      ],
      "overall_sentiment_score": 0.316613,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.340292",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "When Will Strata Critical Medical, Inc. (NASDAQ:SRTA) Breakeven?",
      "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-srta/strata-critical-medical/news/when-will-strata-critical-medical-inc-nasdaqsrta-breakeven/amp",
      "time_published": "20251212T110909",
      "authors": [
        "Simply Wall St"
      ],
      "summary": "Strata Critical Medical, Inc. (NASDAQ:SRTA) is anticipated by analysts to reach breakeven and turn a profit of US$7.0m in 2026, after incurring a final loss in 2025. This projection relies on an optimistic annual growth rate of 171%. The company currently operates with no debt, relying on shareholder funding, which reduces investment risk.",
      "banner_image": "NULL",
      "source": "Simply Wall Street",
      "category_within_source": "General",
      "source_domain": "Simply Wall Street",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.907674"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.817828"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.727038"
        },
        {
          "topic": "finance",
          "relevance_score": "0.634076"
        }
      ],
      "overall_sentiment_score": 0.270008,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.250119",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical (SRTA) appoints Vail Health CEO Will Cook to board, committees",
      "url": "https://www.stocktitan.net/news/SRTA/strata-critical-medical-inc-appoints-will-cook-to-board-of-s42um6guohbb.html",
      "time_published": "20251206T140932",
      "authors": [],
      "summary": "Strata Critical Medical (NASDAQ:SRTA) has appointed Will Cook, the President and CEO of Vail Health, to its Board of Directors, effective December 3, 2025. Mr. Cook will also serve on the Compensation and Nominating and Corporate Governance Committees, bringing extensive healthcare leadership experience to support Strata's organ recovery and logistics platform. This move aims to leverage his industry relationships and expertise to scale operations and further the company's mission to increase organs available for transplant.",
      "banner_image": "https://www.globenewswire.com/newsroom/ti?nf=OTU5NjQzNCM3MzA1MDQ4IzIyNDk4Mjc=",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.920008"
        }
      ],
      "overall_sentiment_score": 0.274827,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.252593",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical Expands Board with New Director",
      "url": "https://www.tipranks.com/news/company-announcements/strata-critical-medical-expands-board-with-new-director",
      "time_published": "20251204T045121",
      "authors": [
        "TipRanks Auto-Generated Newsdesk"
      ],
      "summary": "Strata Critical Medical (SRTA) announced the appointment of William L. Cook, III to its Board of Directors on December 2, 2025. Cook's extensive healthcare experience is expected to bolster the company's efforts to expand its organ recovery and logistics platform. While analysts rate the stock a \"Buy\" with an $8.00 price target, TipRanks' AI Analyst, Spark, assesses SRTA as Neutral due to challenging financial performance despite strategic improvements.",
      "banner_image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Industrials-7-750x406.jpg",
      "source": "TipRanks",
      "category_within_source": "General",
      "source_domain": "TipRanks",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.943366"
        },
        {
          "topic": "finance",
          "relevance_score": "0.738480"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.732837"
        }
      ],
      "overall_sentiment_score": 0.159913,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.168246",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical Appoints New Director",
      "url": "https://www.tradingview.com/news/tradingview:c8d6414d515ce:0-strata-critical-medical-appoints-new-director/",
      "time_published": "20251204T045121",
      "authors": [
        "NULL"
      ],
      "summary": "Strata Critical Medical, Inc. announced the appointment of William L. Cook, III as a Class I director, expanding the board to nine members. His term will expire at the 2027 annual meeting of stockholders. Cook has been appointed to the Compensation and Nominating Committees and is deemed independent under Nasdaq rules.",
      "banner_image": "NULL",
      "source": "TradingView",
      "category_within_source": "General",
      "source_domain": "TradingView",
      "topics": [
        {
          "topic": "finance",
          "relevance_score": "0.846225"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.716860"
        }
      ],
      "overall_sentiment_score": 0.102132,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.112968",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors and Committees, Effective December 3, 2025",
      "url": "https://www.marketscreener.com/news/strata-critical-medical-inc-appoints-will-cook-to-board-of-directors-and-committees-effective-dec-ce7d51dfda80f521",
      "time_published": "20251203T170000",
      "authors": [
        "S&P Capital IQ"
      ],
      "summary": "Strata Critical Medical, Inc. has announced the appointment of Will Cook to its Board of Directors, effective December 3, 2025. Mr. Cook will also serve on the Compensation and Nominating and Corporate Governance Committees. Cook brings extensive experience from his roles as President and CEO of Vail Health and University of Colorado Hospital.",
      "banner_image": null,
      "source": "marketscreener.com",
      "category_within_source": "General",
      "source_domain": "marketscreener.com",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.836843"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.718546"
        }
      ],
      "overall_sentiment_score": 0.199191,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.206973",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors",
      "url": "https://www.globenewswire.com/news-release/2025/12/03/3199402/0/en/Strata-Critical-Medical-Inc-Appoints-Will-Cook-to-Board-of-Directors.html",
      "time_published": "20251203T170000",
      "authors": [],
      "summary": "Strata Critical Medical, Inc. has appointed Will Cook to its Board of Directors, effective December 3, 2025. Cook, currently the President and CEO of Vail Health, brings extensive healthcare experience, having previously held leadership roles at University of Colorado Hospital and UPMC. His appointment is expected to bolster Strata's efforts to expand its organ recovery and logistics platform and explore further medical sector services.",
      "banner_image": "https://ml.globenewswire.com/media/YTZiZmFiMWYtMGVkNS00NTUxLWFjNTUtMjNlYmRlOTU0OGM0LTEyNjEzODAtMjAyNS0xMi0wMy1lbg==/tiny/Strata-Critical-Medical-Inc.png",
      "source": "GlobeNewswire",
      "category_within_source": "General",
      "source_domain": "GlobeNewswire",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.933851"
        },
        {
          "topic": "finance",
          "relevance_score": "0.748571"
        }
      ],
      "overall_sentiment_score": 0.448633,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.436760",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical Appoints Will Cook to Board of Directors",
      "url": "https://www.citybiz.co/article/779596/strata-critical-medical-appoints-will-cook-to-board-of-directors/",
      "time_published": "20251203T151101",
      "authors": [
        "NULL"
      ],
      "summary": "Strata Critical Medical, Inc., a leading provider of logistics and medical services in the organ transplant industry, has appointed Will Cook to its Board of Directors, effective December 3, 2025. Cook, who is the President and CEO of Vail Health, will also serve on the Compensation and Nominating and Corporate Governance Committees. This appointment is expected to provide invaluable healthcare experience and industry relationships as Strata scales its organ recovery and logistics platform and explores broader medical sector services.",
      "banner_image": "https://www.citybiz.co/wp-content/uploads/2025/12/Will-Cook.jpg",
      "source": "citybiz",
      "category_within_source": "General",
      "source_domain": "citybiz",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "1.000000"
        },
        {
          "topic": "finance",
          "relevance_score": "0.607719"
        }
      ],
      "overall_sentiment_score": 0.470759,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.463819",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical, Inc. Appoints Will Cook to Board of Directors",
      "url": "https://finance.yahoo.com/news/strata-critical-medical-inc-appoints-220000474.html",
      "time_published": "20251203T140912",
      "authors": [],
      "summary": "Strata Critical Medical, Inc. has appointed Will Cook to its Board of Directors, effective December 3, 2025. Mr. Cook, who also joins the Compensation and Nominating and Corporate Governance Committees, currently serves as President and CEO of Vail Health. His extensive experience in healthcare leadership is expected to be invaluable as Strata expands its organ recovery and logistics platform and explores new opportunities within the medical sector.",
      "banner_image": null,
      "source": "Yahoo Finance",
      "category_within_source": "General",
      "source_domain": "Yahoo Finance",
      "topics": [
        {
          "topic": "life_sciences",
          "relevance_score": "0.902233"
        },
        {
          "topic": "finance",
          "relevance_score": "0.705480"
        }
      ],
      "overall_sentiment_score": 0.43618,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.449850",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical, Inc. Unveils Growth Strategy and Financial Guidance at 2025 Investor Day | SRTA Stock News",
      "url": "https://www.quiverquant.com/news/Strata+Critical+Medical%2C+Inc.+Unveils+Growth+Strategy+and+Financial+Guidance+at+2025+Investor+Day",
      "time_published": "20251117T191100",
      "authors": [],
      "summary": "Strata Critical Medical, Inc. presented its growth strategy and financial guidance at its 2025 Investor Day, highlighting its leadership in the transplant industry and plans to double organic Adjusted EBITDA by 2029. The company aims to leverage an estimated $200 million for acquisitions to expand its market presence and service delivery. Strata also provided updated 2026 financial guidance, projecting revenues between $255-$270 million and Adjusted EBITDA of $28-$32 million.",
      "banner_image": "https://quiverquant.com/images/srta_rect_new.png",
      "source": "Quiver Quantitative",
      "category_within_source": "General",
      "source_domain": "Quiver Quantitative",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.944204"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.846179"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.717347"
        }
      ],
      "overall_sentiment_score": 0.446319,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.427214",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical (Nasdaq: SRTA) Targets High-Teens EBITDA CAGR, Sets 2026 Guidance",
      "url": "https://www.stocktitan.net/news/SRTA/strata-critical-medical-hosts-2025-investor-day-provides-2026-and-toukj1m7vkr7.html",
      "time_published": "20251117T151101",
      "authors": [],
      "summary": "Strata Critical Medical (Nasdaq: SRTA) held its 2025 Investor Day, providing 2026 guidance and a medium-term framework targeting a high-teens organic Adjusted EBITDA CAGR, aiming to double Adjusted EBITDA by 2029. The company projects 2026 revenue of $255\u2013270 million and Adjusted EBITDA of $28\u201332 million, alongside approximately $200 million in cash available for deployment through 2029 for potential acquisitions in the fragmented transplant industry. Despite the positive outlook, the stock declined 7.10% on the day of the announcement, indicating a negative market reaction.",
      "banner_image": "https://ml.globenewswire.com/media/NDRkOTM4ODAtZDA4NS00ZTE1LWEzZTctZTE0MGNkMzZjY2I0LTEyNjEzODAtMjAyNS0xMS0xNy1lbg==/tiny/Strata-Critical-Medical-Inc.png",
      "source": "Stock Titan",
      "category_within_source": "General",
      "source_domain": "Stock Titan",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.923191"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.742107"
        }
      ],
      "overall_sentiment_score": -0.208184,
      "overall_sentiment_label": "Somewhat-Bearish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "0.950979",
          "ticker_sentiment_score": "-0.204300",
          "ticker_sentiment_label": "Somewhat-Bearish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical, Inc. SEC 10-Q Report",
      "url": "https://www.tradingview.com/news/tradingview:723d456d40a1a:0-strata-critical-medical-inc-sec-10-q-report/",
      "time_published": "20251117T151006",
      "authors": [],
      "summary": "Strata Critical Medical, Inc. (SRTA) released its Q3 2025 10-Q report, revealing significant financial improvements. The company reported $49.3 million in revenue and a net income of $57.4 million, largely due to the sale of its Passenger business. Strata is now focusing on expanding its core medical and logistics services for the transplant industry and integrating its recent acquisition of Keystone Perfusion Services.",
      "banner_image": null,
      "source": "TradingView",
      "category_within_source": "General",
      "source_domain": "TradingView",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "0.912184"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.834655"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.718991"
        }
      ],
      "overall_sentiment_score": 0.435077,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.419969",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical Hosts 2025 Investor Day; Provides 2026 and Medium-Term Financial Guidance",
      "url": "https://www.globenewswire.com/news-release/2025/11/17/3189511/0/en/Strata-Critical-Medical-Hosts-2025-Investor-Day-Provides-2026-and-Medium-Term-Financial-Guidance.html",
      "time_published": "20251117T140000",
      "authors": [
        "NULL"
      ],
      "summary": "Strata Critical Medical, Inc. (Nasdaq: SRTA) hosted its 2025 Investor Day, highlighting industry growth catalysts and outlining financial targets. The company provided 2026 guidance and a medium-term financial framework, projecting a high-teens organic Adjusted EBITDA CAGR, leading to a doubling of Adjusted EBITDA by 2029. Strata also emphasized its significant roll-up opportunity in a fragmented market, with approximately $200 million available for deployment through 2029.",
      "banner_image": "https://ml.globenewswire.com/media/NDRkOTM4ODAtZDA4NS00ZTE1LWEzZTctZTE0MGNkMzZjY2I0LTEyNjEzODAtMjAyNS0xMS0xNy1lbg==/tiny/Strata-Critical-Medical-Inc.png",
      "source": "GlobeNewswire",
      "category_within_source": "General",
      "source_domain": "GlobeNewswire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.933261"
        },
        {
          "topic": "finance",
          "relevance_score": "0.818921"
        },
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.704821"
        }
      ],
      "overall_sentiment_score": 0.448893,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.428878",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Earnings call transcript: Strata Critical Medical\u2019s Q3 2025 reveals revenue miss, stock rises",
      "url": "https://www.investing.com/news/transcripts/earnings-call-transcript-strata-critical-medicals-q3-2025-reveals-revenue-miss-stock-rises-93CH-4346265",
      "time_published": "20251110T090100",
      "authors": [
        "Investing.com"
      ],
      "summary": "Strata Critical Medical (SRTA) reported a significant revenue and EPS miss for Q3 2025, with an EPS of -$0.12 against an expected $0.02 and revenue of $49.3 million against a forecasted $61.31 million. Despite these misses, the stock rose 7.67% in premarket trading, reflecting investor optimism due to a 36.7% year-over-year revenue increase, strategic acquisitions, new product launches, and raised 2025 revenue guidance to $185-$195 million. The company emphasizes its transformation into an end-to-end organ recovery platform and plans to consolidate market share in the fragmented organ transplant industry.",
      "banner_image": "https://i-invdn-com.investing.com/news/World_News_9_800x533_L_1420026261.jpg",
      "source": "Investing.com",
      "category_within_source": "General",
      "source_domain": "Investing.com",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.916540"
        }
      ],
      "overall_sentiment_score": 0.315072,
      "overall_sentiment_label": "Somewhat-Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.346911",
          "ticker_sentiment_label": "Somewhat-Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical Announces Third Quarter 2025 Results",
      "url": "https://www.globenewswire.com/news-release/2025/11/10/3184379/0/en/Strata-Critical-Medical-Announces-Third-Quarter-2025-Results.html",
      "time_published": "20251110T070000",
      "authors": [],
      "summary": "Strata Critical Medical, Inc. reported increased revenue of $49.3 million in Q3 2025, up 36.7% year-over-year, and a significant 93.5% increase in Medical Segment Adjusted EBITDA to $7.6 million. The company recently completed the divestiture of its Passenger business and acquired Keystone Perfusion, leading to a sharpened focus on the healthcare sector. Strata has raised its 2025 revenue guidance to $185-195 million and reaffirmed its Adjusted EBITDA guidance of $13-14 million.",
      "banner_image": "https://ml.globenewswire.com/media/NGNhMWRkNjctNmNkMi00NjBhLWI3ZTgtZjZiZTJjOWVlNjg2LTEyNjEzODAtMjAyNS0xMS0xMC1lbg==/tiny/Strata-Critical-Medical-Inc.png",
      "source": "GlobeNewswire",
      "category_within_source": "General",
      "source_domain": "GlobeNewswire",
      "topics": [
        {
          "topic": "earnings",
          "relevance_score": "1.000000"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.744637"
        }
      ],
      "overall_sentiment_score": 0.408909,
      "overall_sentiment_label": "Bullish",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "1.000000",
          "ticker_sentiment_score": "0.433575",
          "ticker_sentiment_label": "Bullish"
        }
      ]
    },
    {
      "title": "Strata Critical Medical Sells Passenger Unit To Joby, Focuses On Healthcare Logistic",
      "url": "https://www.nasdaq.com/articles/strata-critical-medical-sells-passenger-unit-joby-focuses-healthcare-logistic",
      "time_published": "20250829T181000",
      "authors": [
        "RTTNews.com"
      ],
      "summary": "Strata Critical Medical (formerly Blade Air Mobility) has sold its Passenger division to Joby Aviation, shifting its full focus to medical air transportation, specifically organ transplant logistics. The sale involves an initial payment in Joby stock, with further payments contingent on performance milestones and employee retention. Strata, now trading as SRTA, exhibits financial stability from its healthcare logistics segment despite negative operating and net margins, with analysts maintaining a positive outlook.",
      "banner_image": null,
      "source": "Nasdaq",
      "category_within_source": "General",
      "source_domain": "Nasdaq",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.801996"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.741138"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.711043"
        },
        {
          "topic": "financial_markets",
          "relevance_score": "0.640757"
        },
        {
          "topic": "energy_transportation",
          "relevance_score": "0.548875"
        }
      ],
      "overall_sentiment_score": 0.029868,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "0.331772",
          "ticker_sentiment_score": "0.021972",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    },
    {
      "title": "Blade Completes Sale of Passenger Business and Planned Name Change to Strata Critical Medical, Begins Trading Under Ticker Symbol SRTA",
      "url": "https://www.globenewswire.com/news-release/2025/08/29/3141471/0/en/Blade-Completes-Sale-of-Passenger-Business-and-Planned-Name-Change-to-Strata-Critical-Medical-Begins-Trading-Under-Ticker-Symbol-SRTA.html",
      "time_published": "20250829T083000",
      "authors": [],
      "summary": "Strata Critical Medical, Inc., formerly Blade Air Mobility, Inc., has completed the sale of its Passenger business to Joby Aviation, Inc. and has rebranded to focus entirely on critical medical logistics. The company will now trade under the ticker symbol SRTA and has updated its 2025 financial guidance to reflect this divestiture, projecting $160-170 million in revenue and double-digit Adjusted EBITDA. Strata Critical Medical specializes in organ transplant logistics and plans to expand its medical services through organic growth, partnerships, and acquisitions.",
      "banner_image": "https://ml.globenewswire.com/media/ZjM3MmU4MjEtMmMxOC00Y2IxLThkODktMjdhM2VmMDUzYTBiLTEyNjEzODAtMjAyNS0wOC0yOS1lbg==/tiny/Blade-Air-Mobility-Inc-.png",
      "source": "GlobeNewswire",
      "category_within_source": "General",
      "source_domain": "GlobeNewswire",
      "topics": [
        {
          "topic": "mergers_and_acquisitions",
          "relevance_score": "0.940568"
        },
        {
          "topic": "earnings",
          "relevance_score": "0.858276"
        },
        {
          "topic": "life_sciences",
          "relevance_score": "0.742528"
        },
        {
          "topic": "energy_transportation",
          "relevance_score": "0.497903"
        }
      ],
      "overall_sentiment_score": 0.023246,
      "overall_sentiment_label": "Neutral",
      "ticker_sentiment": [
        {
          "ticker": "SRTA",
          "relevance_score": "0.320263",
          "ticker_sentiment_score": "0.005555",
          "ticker_sentiment_label": "Neutral"
        }
      ]
    }
  ]
}